398
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth

, , , , , , , & show all
Pages 754-760 | Received 24 Sep 2020, Accepted 16 Jan 2021, Published online: 01 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Theo Borgovan, Niranjan Yanamandra & Hank Schmidt. (2022) Innate immunity as a target for novel therapeutics in triple negative breast cancer. Expert Opinion on Investigational Drugs 31:8, pages 781-794.
Read now

Articles from other publishers (8)

Mingtong Ma, Yifang Dang, Boran Chang, Fei Wang, Junfang Xu, Li Chen, Hang Su, Jinsong Li, Baoxue Ge, Chang Chen & Haipeng Liu. (2023) TAK1 is an essential kinase for STING trafficking. Molecular Cell 83:21, pages 3885-3903.e5.
Crossref
Qianhua Wu, Genyi Jiang, Yihan Sun & Bilan Li. (2023) Reanalysis of single-cell data reveals macrophage subsets associated with the immunotherapy response and prognosis of patients with endometrial cancer. Experimental Cell Research 430:2, pages 113736.
Crossref
Michelle L. Bookstaver, Qin Zeng, Robert S. Oakes, Senta M. Kapnick, Vikas Saxena, Camilla Edwards, Nishedhya Venkataraman, Sheneil K. Black, Xiangbin Zeng, Eugene Froimchuk, Thomas Gebhardt, Jonathan S. Bromberg & Christopher M. Jewell. (2022) Self‐Assembly of Immune Signals to Program Innate Immunity through Rational Adjuvant Design. Advanced Science 10:1.
Crossref
Rui Yang, Sihui Yu, Tianhan Xu, Jiawen Zhang & Sufang Wu. (2022) Emerging role of RNA sensors in tumor microenvironment and immunotherapy. Journal of Hematology & Oncology 15:1.
Crossref
Run Zheng & Jian Ma. (2022) Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment. Pharmaceutics 14:11, pages 2285.
Crossref
Lina Jing, Xin Zhang, Dong Liu, Yonghong Yang, Huabao Xiong & Guanjun Dong. (2022) ACK1 Contributes to the Pathogenesis of Inflammation and Autoimmunity by Promoting the Activation of TLR Signaling Pathways. Frontiers in Immunology 13.
Crossref
Sehwan Jeong, Yunyoung Choi & Kyobum Kim. (2021) Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists. Pharmaceutics 13:9, pages 1374.
Crossref
Mingming Song, Chang Liu, Siyu Chen & Wenxiang Zhang. (2021) Nanocarrier-Based Drug Delivery for Melanoma Therapeutics. International Journal of Molecular Sciences 22:4, pages 1873.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.